Business Today
Subscribe
IndiaNRICareer & JobsUS NewsWeatherPetrol PricesDiesel PricesPMS TodayBT Reels
EY Business Today Hidden Gems 2026BT MindrushBT India 100
Search
Advertisement
Business News
markets
stocks
Q-Line Biotech Ltd
Q-Line Biotech Ltd

Q-Line Biotech Ltd (QLINE) Share Price

  • Sector: Trading (Small Cap)
  • Volume: 4,03,200
Jun 19, 2026
  • NSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹562.60
₹36.75 (6.99%)
527.00Low
Today’s Performance
568.00High
431.00Low
52 Week’s Performance
568.00High

bt_logoStock Analysis

bt_logoStock Performance

  • 1 Day6.99%
  • 1 Week10.47%
  • 1 Month18.54%
  • 3 Months-%
  • 6 Months-%
  • 1 Year-%
  • 3 Years-%
  • 5 Years-%

bt_logoStock Summary

  • Face Value (₹)10.00
  • Beta-0.31
  • 52-Week Low (₹)431.00
  • 52-Week High (₹)568.00
  • Price-to-Book (X)*2.69
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*23.55
  • Earnings Per Share (₹)23.89
  • Market Cap (₹ Cr.)*1,312.44
* Values as of last close price

bt_logoCOMPETITORS

BT TV

How Ashishkumar Chauhan Revived NSE & Cleared The IPO Path23:22How Ashishkumar Chauhan Revived NSE & Cleared The IPO Path
Software Stocks Fell Sharply On Accenture's Guidance Cut; Nifty Slips4:58Software Stocks Fell Sharply On Accenture's Guidance Cut; Nifty Slips
"Fast-Track Growth": SEBI Launches GARUDA For AIFs And Aligns SDI Rules With RBI Standards5:33"Fast-Track Growth": SEBI Launches GARUDA For AIFs And Aligns SDI Rules With RBI Standards
Indian IT Stocks Crash To Multi-Year Lows Following Accenture’s Weak Revenue Guidance3:05Indian IT Stocks Crash To Multi-Year Lows Following Accenture’s Weak Revenue Guidance
Reliance Industries Stock Falls: Is RIL A Buy Low Opportunity Or A Value Trap?3:04Reliance Industries Stock Falls: Is RIL A Buy Low Opportunity Or A Value Trap?
Ayodhya Donation Probe: Nripendra Misra Demands Full Transparency As SIT Investigation Intensifies11:23Ayodhya Donation Probe: Nripendra Misra Demands Full Transparency As SIT Investigation Intensifies
SEBI Simplifies Securities Transmission And Revives Open-Market Buybacks From August 1, 20267:03SEBI Simplifies Securities Transmission And Revives Open-Market Buybacks From August 1, 2026
Delhi High Court Upholds Telegram Ban To Ensure Integrity Of NEET-UG Re-Test3:14Delhi High Court Upholds Telegram Ban To Ensure Integrity Of NEET-UG Re-Test
Lower Crude Oil Prices Could Boost Indian Stock Market: Dalal Street Outlook Explained1:56Lower Crude Oil Prices Could Boost Indian Stock Market: Dalal Street Outlook Explained
MobiKwik Targets ₹5,000 Crore Lending Disbursals, Aims To Double Profitability In FY273:34MobiKwik Targets ₹5,000 Crore Lending Disbursals, Aims To Double Profitability In FY27
View more

bt_logoFAQs

What was Q-Line Biotech Ltd share price previously?
Q-Line Biotech Ltd share price was up by 6.99% from the previous closing price of ₹525.85.
Who are peers of Q-Line Biotech Ltd?
The peers of Q-Line Biotech Ltd are Adani Enterprises Ltd, Premier Energies Ltd, Aegis Logistics Ltd, Redington Ltd, Honasa Consumer Ltd, Lloyds Enterprises Ltd, MMTC Ltd, Cello World Ltd, SG Mart Ltd, GNG Electronics Ltd.
Who is/are the promoter/promoters of Q-Line Biotech Ltd?
The promotor/promotors of Q-Line Biotech Ltd are Saurabh Garg, Kuldeep Chowdhry, Ajay Kumar Mahanty, Yethadka Subraya Prabhakara, Abhay Agrawal, Amita Garg, Ayush Garg, Abhishek Mishra, Pravir Kumar, ROHIT NANDAN, Jai Prakash Singh, Akhand Pratap Singh..
What has been 52-week high of Q-Line Biotech Ltd stocks?
The highest price of Q-Line Biotech Ltd stock is ₹568.00 in the last 52-week.
What is the share price of Q-Line Biotech Ltd (QLINE) today on NSE?
As on Jun 19, 2026 Q-Line Biotech Ltd (QLINE)’s share price on NSE is Rs 562.6
What is the market cap of Q-Line Biotech Ltd (QLINE)?
The current market capitalisation of Q-Line Biotech Ltd (QLINE) is 1,312.44 crores
What is Q-Line Biotech Ltd Share symbol?
The symbol of Q-Line Biotech Ltd is QLINE.
What is the PE ratio of Q-Line Biotech Ltd (QLINE)?
The current PE ratio of Q-Line Biotech Ltd (QLINE) is 23.55.
What is the PB ratio of Q-Line Biotech Ltd (QLINE)?
The current PB ratio of Q-Line Biotech Ltd (QLINE) is 2.69.
Today’s High & Low share prices of Q-Line Biotech Ltd (QLINE) on NSE?
Today, the share price of Q-Line Biotech Ltd (QLINE) on NSE touched a high of Rs 568 and a low of Rs 527
What price did Q-Line Biotech Ltd (QLINE) shares open on the NSE today?
On NSE, the share price of Q-Line Biotech Ltd (QLINE) opened at Rs 528.95
What is the 52-week high of Q-Line Biotech Ltd (QLINE)?
The 52-week high price of Q-Line Biotech Ltd (QLINE) is Rs 568.00
What is the 52-week low of Q-Line Biotech Ltd (QLINE)?
The 52-week low price of Q-Line Biotech Ltd (QLINE) is Rs 431.00

bt_logoAbout Q-Line Biotech

Q-Line Biotech Ltd, incorporated in the year 2010, has its registered office in 298-281 Transport Nagar Kanpur, #NAME?, Lucknow, Uttar Pradesh, 226012, +91 522 2435 570. The main industry in which Q-Line Biotech Ltd operates is Trading.

Auditor/Auditors for Q-Line Biotech Ltd is/are . In the main management, Saurabh Garg is chairman and Akhand Pratap Singh. is the company secretary for Q-Line Biotech Ltd.

  • SG
    Saurabh GargChairman & Managing Director
  • KC
    Kuldeep ChowdhryWhole Time Director
  • AKM
    Ajay Kumar MahantyWhole-time Director
  • YSP
    Yethadka Subraya PrabhakaraWhole-time Director
  • AA
    Abhay AgrawalNon Executive Director
  • AG
    Amita GargNon Executive Director
  • AG
    Ayush GargNon Executive Director
  • AM
    Abhishek MishraIndependent Director
  • PK
    Pravir KumarIndependent Director
  • RN
    ROHIT NANDANIndependent Director
  • JPS
    Jai Prakash SinghIndependent Director
  • APS
    Akhand Pratap Singh.Company Secretary / Compliance Officer

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.